
Sign up to save your podcasts
Or
In this episode of the Growing a Successful Orthopedic Practice Podcast, Jeff Segal, M.D., J.D., CEO and Founder of Medical Justice, joins Keith Landry to discuss how orthopedic physicians can use stem-cell therapies and other cutting edge treatments in their practices while limiting liability.
Dr. Segal explains if a physician manipulates stem cells and puts them back into the body to serve a different purpose than the original one, the FDA treats that like a drug and will likely require a new drug application. He reminds us a physician's claims about the benefits of stem-cell therapy must be supported by medical literature.
Tune in to discover:
About Dr. Jeff Segal
Dr. Jeff Segal, Chief Executive Officer and Founder of Medical Justice, is a board-certified neurosurgeon. He was a practicing neurosurgeon for approximately ten years, during which time he also played an active role as a participant on various state-sanctioned medical review panels designed to decrease the incidence of meritless medical malpractice cases. Dr. Segal holds a M.D. from Baylor College of Medicine, where he also completed a neurosurgical residence. Dr. Segal also graduated with a J.D. from Concord Law School with highest honors. He is also a partner at Byrd Adatto, a national business and health care law firm.
About Keith Landry
Keith Landry is Director of Public Relations at Insight Marketing Group. Keith has been a public relations consultant since 2010. He has more than 26 years of experience as a news anchor, news reporter and public affairs show host, which he uses to implement innovative public relations strategies for medical practice clients.
4.7
33 ratings
In this episode of the Growing a Successful Orthopedic Practice Podcast, Jeff Segal, M.D., J.D., CEO and Founder of Medical Justice, joins Keith Landry to discuss how orthopedic physicians can use stem-cell therapies and other cutting edge treatments in their practices while limiting liability.
Dr. Segal explains if a physician manipulates stem cells and puts them back into the body to serve a different purpose than the original one, the FDA treats that like a drug and will likely require a new drug application. He reminds us a physician's claims about the benefits of stem-cell therapy must be supported by medical literature.
Tune in to discover:
About Dr. Jeff Segal
Dr. Jeff Segal, Chief Executive Officer and Founder of Medical Justice, is a board-certified neurosurgeon. He was a practicing neurosurgeon for approximately ten years, during which time he also played an active role as a participant on various state-sanctioned medical review panels designed to decrease the incidence of meritless medical malpractice cases. Dr. Segal holds a M.D. from Baylor College of Medicine, where he also completed a neurosurgical residence. Dr. Segal also graduated with a J.D. from Concord Law School with highest honors. He is also a partner at Byrd Adatto, a national business and health care law firm.
About Keith Landry
Keith Landry is Director of Public Relations at Insight Marketing Group. Keith has been a public relations consultant since 2010. He has more than 26 years of experience as a news anchor, news reporter and public affairs show host, which he uses to implement innovative public relations strategies for medical practice clients.